Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Can B-Cells Predict Which MS Patients Respond to Treatment?
Genetics
Can B-Cells Predict Which MS Patients Respond to Treatment?

20, Aug 2025

2
Can B-Cells Predict Which MS Patients Respond to Treatment?
Genetics
Ocrelizumab’s Hidden Effect: How an MS Therapy Rewires B-Cell Communication

20, Aug 2025

3
Fingolimod’s Hidden Talent: Calming the Immune Cells That Fuel MS
Genetics
Fingolimod’s Hidden Talent: Calming the Immune Cells That Fuel MS

18, Aug 2025

4
Vitamin D Puzzle in Multiple Sclerosis: Natural Analogs and Genetic Insights into Treatment Resistance
Genetics
Vitamin D Puzzle in Multiple Sclerosis: Natural Analogs and Genetic Insights into Treatment Resistance

18, Aug 2025

5
Does a Genetic Variant Protect Against MS Relapses? What the CCR5-Δ32 Story Teaches Us About Treatment with Natalizumab
Genetics
Does a Genetic Variant Protect Against MS Relapses? What the CCR5-Δ32 Story Teaches Us About Treatment with Natalizumab

17, Aug 2025

Categories:
Genetics
Tissue Markers and Personalized Medicine and Treatment Response in Multiple Sclerosis
Genetics
Tissue Markers and Personalized Medicine and Treatment Response in Multiple Sclerosis

09, Jun 2025

Genetics and Drug Response in MS: Why Some Patients Benefit More from First-Line Treatments
Genetics
Genetics and Drug Response in MS: Why Some Patients Benefit More from First-Line Treatments

10, Jun 2025

Plasma GFAP: A Promising Biomarker for Disease Progression and Treatment Response in Secondary Progressive MS
Genetics
Plasma GFAP: A Promising Biomarker for Disease Progression and Treatment Response in Secondary Progressive MS

11, Jun 2025

Could Paraoxonase1 (PON1) Be the Unsung Hero in Multiple Sclerosis Treatment Monitoring?
Genetics
Could Paraoxonase1 (PON1) Be the Unsung Hero in Multiple Sclerosis Treatment Monitoring?

12, Jun 2025